A study published in Nature divided into ten subtypes of breast cancer. The work done at Cambridge and Canada analyzed two groups of one thousand samples each of breast cancer worldwide, with clinical data from up to ten years, and studied the mutated genes, amplicons, or more than normal activity, the inherited and acquired.
From all this have come out ten subtypes of cancer, listed under the name IntClust and a number from one to ten: IntClust2, quite rare, has a poor prognosis, 3 and 4-the most common, 15% of the cases-very good, those of 1, 6, 7, 8 and 9 have an intermediate severity, the 5 has a poor prognosis the first five years, but surpassed that stage gives good prospects of cure. It is estimated that in five years this knowledge may be applied, via treatment, patients in the clinic.
I think that´s better to humans, because can you imagine a person who has cancer and with this development suffers less? It will be fantastic, both for people who suffer and for people who care for sicks.